1. Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer. Issue 1 (1st January 2021) Authors: Schofield, Darren J.; Percival-Alwyn, Jennifer; Rytelewski, Mateusz; Hood, John; Rothstein, Raymond; Wetzel, Leslie; McGlinchey, Kelly; Adjei, Grace; Watkins, Amanda; Machiesky, LeeAnn; Chen, Weimin; Andrews, John; Groves, Maria; Morrow, Michelle; Stewart, Ross A.; Leinster, Andrew; Wilkinson, Ro... Journal: MAbs Issue: Volume 13:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗